Nanoplatforms for Cancer Theranostics · Journal article
Acs Nano Medicine · September 7, 2026
Raises a question worth testing. It does not answer one.
This is a narrative review of an emerging therapeutic strategy coupling photodynamic therapy with self-propelled micro- and nanomotors to enhance photosensitizer transport and mitigate hypoxia. The source synthesizes mechanistic concepts and early-stage in vitro and in vivo work but does not report original efficacy data, clinical outcomes, or comparative effectiveness.
Journal article.
Active MNM motion enhances photosensitizer transport and localization Oxygen-generating or oxygen-supplying MNM platforms can partially mitigate hypoxia-related limitations of PDT Combination strategy integrates photodynamic activity with autonomous propulsion
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
This is a narrative review article synthesizing emerging concepts in combining micro/nanomotors with photodynamic therapy; it raises mechanistic questions and describes early-stage approaches rather than reporting primary evidence of clinical or preclinical efficacy.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no reported figures. That is a gap in the analysis, not a judgement about the study.
Abstract Photodynamic therapy (PDT) is a clinically relevant and minimally invasive strategy for treating diseases associated with uncontrolled tissue growth, including nonmelanoma skin cancers and microbial infections. Its spatiotemporal selectivity minimizes damage to healthy tissues and limits the emergence of therapeutic resistance, while its versatility enables integration with complementary therapeutic approaches. One emerging direction is the combination of PDT with artificial self-propelled micro- and nanomotors (MNMs). Active MNM motion enhances photosensitizer (PS) transport and localization, while oxygen-generating or oxygen-supplying MNM platforms can partially mitigate hypoxia-related limitations of PDT. This Review provides a comprehensive overview of recent advances in MNM-assisted PDT, highlighting commonly used PS molecules and strategies for their integration into MNMs to couple photodynamic activity with autonomous propulsion. It examines representative in vitro and in vivo studies, identifies critical performance parameters and current challenges, and explores future opportunities for the rational design of next-generation self-propelled phototherapeutic systems.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.